Doctor profile · Federal record
Dr. Sowjanya Reganti, M.D.,
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Reno, NV
- NPI 1356482020
- Accepts Medicare
- MIPS 69.9 / 100 · 2023
- 26 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
5423 Reno Corporate Dr.
Reno, NV 895112250
(775) 329-0873
fax (775) 329-1026 - Mailing address
-
5423 Reno Corporate Dr
Reno, NV 895112250
Credentials & registration
- NPI registered
- February 2007 — 19 yrs on file
- Profile last updated
- May 22, 2019
- Year of graduation
- 2000 — 26 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Nevada #12627
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1356482020. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
50,494
Distinct HCPCS
10
Medicare allowed
$1,645,004
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J9299 |
Injection, nivolumab, 1 mg | 13,560 | 12 | $30 | |
J0897 |
Injection, denosumab, 1 mg | 11,820 | 60 | $23 | |
J9271 |
Injection, pembrolizumab, 1 mg | 10,000 | 14 | $54 | |
J0894 |
Injection, decitabine, 1 mg | 2,350 | 12 | $2 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 1,596 | 49 | $0 | |
J9041 |
Injection, bortezomib, 0.1 mg | 1,400 | 14 | $5 | |
J9395 |
Injection, fulvestrant, 25 mg | 1,380 | 11 | $10 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 1,150 | 38 | $1 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 1,061 | 487 | $127 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 985 | 344 | $7 |
In context: peer comparison
Among 8 peers in this city , average services per provider: 1,102. This provider delivers 46× the peer median.Open Payments
Industry payments received
All-time total
$8,147
Transactions
44
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Daiichi Sankyo Inc. | 11 | $5,920.48 | |
| AstraZeneca Pharmaceuticals LP | 6 | $1,484.11 | |
| E.R. Squibb & Sons, L.L.C. | 4 | $110.11 | |
| PFIZER INC. | 5 | $86.32 | |
| Merck Sharp & Dohme LLC | 3 | $76.45 | |
| Genentech USA, Inc. | 3 | $66.23 | |
| SpringWorks Therapeutics, Inc. | 2 | $58.26 | |
| Mirati Therapeutics, Inc. | 2 | $49.99 | |
| Ipsen Biopharmaceuticals, Inc | 2 | $48.61 | |
| Deciphera Pharmaceuticals Inc. | 1 | $38.64 | |
| Regeneron Healthcare Solutions, Inc. | 1 | $36.26 | |
| Eisai Inc. | 1 | $31.88 | |
| Kyowa Kirin, Inc. | 1 | $28.30 | |
| Verity Pharmaceuticals Inc. | 1 | $28.15 | |
| GlaxoSmithKline, LLC. | 1 | $24.35 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,950
Patients
539
Total drug cost
$2,122,791
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 1,050 | 325 | $33,726 |
| Alendronate Sodium | Generic | 266 | 104 | $3,420 |
| Letrozole | Generic | 143 | 42 | $4,167 |
| Exemestane | Generic | 78 | 24 | $14,212 |
| Tamoxifen Citrate | Generic | 76 | 33 | $2,715 |
| Gabapentin | Generic | 48 | 0 | $867 |
| Verzenio (Abemaciclib) | Brand | 48 | 0 | $742,402 |
| Acyclovir | Generic | 46 | 0 | $503 |
| Jakafi (Ruxolitinib Phosphate) | Brand | 37 | 0 | $536,930 |
| Hydroxyurea | Generic | 36 | 0 | $1,059 |
Hospital affiliations
Frequently asked questions
What is Dr. Sowjanya Reganti's medical specialty?
Dr. Sowjanya Reganti practices Hematology & Oncology Physician in Reno, NV.
Where does Dr. Sowjanya Reganti practice?
Dr. Sowjanya Reganti practices at 5423 Reno Corporate Dr., Reno, NV 895112250. Office phone: 7753290873.
What is Dr. Sowjanya Reganti's NPI?
Dr. Sowjanya Reganti's National Provider Identifier (NPI) is 1356482020, issued by NPPES.
Does Dr. Sowjanya Reganti accept Medicare assignment?
Yes. Dr. Sowjanya Reganti accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Sowjanya Reganti commonly perform?
Top Medicare-reported procedures in 2023: Injection, nivolumab, 1 mg (HCPCS J9299); Injection, denosumab, 1 mg (HCPCS J0897); Injection, pembrolizumab, 1 mg (HCPCS J9271). Source: CMS Medicare Physician & Other Practitioners file.